Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Phase 1 MRX1 Study Delivers Strong Headline Data
Contributed by:
PR Newswire
Tags
Ananda-Pharma-Limited
More Like This
ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis
ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain
Sapient Therapeutics Announces Positive Phase 1 Results in Part B of Its Solid Dose Prescription CBD Study
Orexo announces positive outcome from an in-vivo study of OX390
Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations
Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health
Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients
ANANDA Scientific and the David Geffen School of Medicine, UCLA, Announce Commencement of a Clinical Trial Evaluating Nantheia™ ATL5 for Smoking Cessation
